Hans-Reiner Figulla

Showing 1-5 of 5 articles

Interventions for valvular disease

Tricuspid valve interventions in 2015

Lauten A, Figulla HR

September 17, 2015 | 10.4244/EIJV11SWA37

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

Renal denervation with cryoenergy as second-line option is effective in the treatment of resistant hypertension in non-responders to radiofrequency ablation

Prochnau D, Heymel S, Otto S, Figulla HR, Surber R

September 28, 2014 | 10.4244/EIJV10I5A110

Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?

Unverdorben M, Kleber F-X, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B

September 27, 2013 | 10.4244/EIJV9I5A99

Treede H, Rastan A, Ferrari M, Ensminger S, Figulla HR, Mohr F

September 30, 2012 | 10.4244/EIJV8SQA16

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Hinge point-based aortic annular plane

September 18, 2020

Ahead of print: Histopathology of embolic debris during TAVI

September 18, 2020

Transcatheter VIV implantation for failed surgical bioprostheses

September 18, 2020

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Over 10,000 followers

September 18, 2020

Steady-state hyperaemia: many routes, one goal

September 18, 2020

This Week's JAA's: Leaflex study, Coronary access after REDO-TAVI...

September 15, 2020

Valvular disease